Diuretics and chronic lung disease of prematurity

Journal of Perinatology

Volumn 21, Issue 5, 2001, Pages 269-271

  Brion, Luc P ^a   Chuen Yong, Sin ^b   Perez, Iris A ^a   Primhak, Robert ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; OXYGEN; RETINOL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ACID BASE BALANCE; AIRWAY RESISTANCE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; DRUG MECHANISM; EDEMA; EDITORIAL; ELECTROLYTE DISTURBANCE; HEARING LOSS; HUMAN; HYPOTENSION; HYPOVOLEMIA; KIDNEY CALCIFICATION; LUNG ALVEOLUS; LUNG COMPLIANCE; LUNG INTERSTITIUM; MORTALITY; NEWBORN; NURSERY; OSTEOPENIA; OUTCOMES RESEARCH; OXYGEN CONSUMPTION; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PROGNOSIS;

BRONCHOPULMONARY DYSPLASIA; DIURETICS; HUMANS; INFANT, NEWBORN; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034855273     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200526     Document Type: Editorial

References (26)

1. Pulmonary disease following respiratory therapy of hyaline membrane disease: Bronchopulmonary dysplasia
2. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period
3. Bronchopulmonary dysplasia: Possible relationship to pulmonary edema
4. Intravenous or enteral administration of a loop diuretic in preterm infants with (or developing) chronic lung disease
5. Aerosolized furosemide in preterm infants with or developing chronic lung disease
6. Distal diuretics in preterm infants with or developing chronic lung disease
7. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia
8. Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia
9. Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: A double-blind, placebo-controlled, randomized trial
10. Controlled trial of furosemide therapy in infants with chronic lung disease
11. Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia
12. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia
13. The effect of aerosolized furosemide in infants with chronic lung disease
14. Effects of nebulized furosemide vs. normal saline on pulmonary mechanics in bronchopulmonary dysplasia
15. Drug treatment for established BPD
16. Effect of diuretics on urinary oxalate, calcium and sodium excretion in very low birth weight infants
17. Renal disease
18. Prophylactic surfactant vs. treatment with surfactant
19. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies
20. Synchronized mechanical ventilation in neonates
21. Effect of minimal ventilation in a multicenter randomized controlled trial of ventilator support and early corticosteroid therapy in extremely low birth weight infants
22. Vitamin A. supplementation for preventing morbidity and mortality in very low birthweight infants
23. Prophylactic post-extubation nasal CPAP in preterm infants
24. Prevention of respiratory syncytial virus infections: Indications for the use of Palivizumab and update on the use of RSV-IGIV
25. Neonatal controversies
26. Serious complications in a randomized trial of early stress dose dexamethasone in extremely low birth weight infants